LAG3 and neoplasm: Another important distinction was the tumor-associated presence (2% of CD3+ T cells) of Lag3+ Granzyme B+ cytotoxic T cells (“TcEFF_II”) within the liver but not in the lung microenvironment (Fig. 2a).